Abstract. Behavioral assessments of hindlimb motor recovery and anatomical assessments of extended axons of long spinal tracts were conducted in adult rats following complete spinal cord transection. Rats were randomly divided into 3 groups: 1) sham control group (laminectomy only; n ϭ 12); 2) transection-only group, spinal cord transection at T8 (n ϭ 20); and 3) experimental treatment group, spinal cord transection at T8, with peripheral nerve grafts (PNG) and application of acidic fibroblast growth factor (aFGF) (n ϭ 14). The locomotor behavior and stepping of all rats were analyzed over a 6-month survival time using the Basso, Beattie, Bresnahan (BBB) open field locomotor test and the contact placing test. Immunohistochemistry for serotonin (5-HT), anterograde tracing with biotinylated dextran amine (BDA), and retrograde tracing with fluoro-gold were used to evaluate the presence of axons below the damage site following treatment. When compared with the transection-only group, the nerve graft with the aFGF group showed 1) significant improvement in hindlimb locomotion and stepping, 2) the presence of 5-HT-labeled axons below the lesion site at lumbar cord level (these were interpreted as regenerated axons from the raphe nuclei), 3) the presence of anterograde BDA labeling of corticospinal tract axons at the graft site and below, and 4) fluoro-gold retrograde labeling of neuron populations in motor cortex and in red nucleus, reticulospinal nuclei, raphe nuclei, and vestibular nuclei. We conclude that peripheral nerve grafts and aFGF treatments facilitate the regrowth of the spinal axons and improve hindlimb function in a T-8 spinal cord-transected rat model.
INTRODUCTION
The complete transection of the adult mammalian spinal cord is believed to lead to irreparable, permanent loss of connectivity. The execution of coordinated movements depends on control exerted by higher centers in the brain. After transection in the rat spinal cord, the neurons responsible for contraction of muscles of the hindlimb, which are located in the lumbar enlargements of the cord, are left intact but are not functional because of lack of connections from the supraspinal control pathways (1) (2) (3) . One necessary element of recovery in post-traumatic spinal cord is long tract axonal regeneration. Pathological changes after spinal cord injury (including scar formation, myelin inhibition, neuronal apoptosis, or necrosis) limit axonal regeneration after the injury (4, 5) . Several successful repair strategies have demonstrated that regenerated axons can grow beyond the lesion site if provided an appropriate environment (6) (7) (8) (9) . In a previous study we showed that a favorable environment for axon regeneration can be created by surgical repair of peripheral nerve transplantation and aFGF treatment (10) . These results demonstrated better hindlimb functional recovery in a treatment that combined aFGF and nerve grafts than the California, Irvine. Rats were divided into 3 groups. The first group was a sham control group that had laminectomy only (n ϭ 12). The spinal cords of rats in another 2 groups were completely transected at T8 and a 5-mm gap was created by removal of spinal cord tissue. The transection-only group (n ϭ 20) had spinal cord transection but no additional treatment. The nerve graft with aFGF group (n ϭ 14) received grafts of intercostal peripheral nerve segments into the 5-mm gap and were treated with fibrin mixture containing aFGF.
Surgical Procedures
All surgery was done under general ketamine (70 mg/kg) and xylazine (8 mg/kg) anesthesia. Rats were maintained on a heating pad and the rectal temperature was monitored and maintained within 3ЊC of normal temperature during surgery. In the sham control group, rats received a laminectomy without any spinal cord damage. In the transection-only group, following laminectomy, 2 complete oblique transverse cuts separated by 5 mm were made through the spinal cord at near T8 level. The 5-mm block of the spinal cord tissue between the 2 transverse cuts was completely removed, leaving the 2 stumps of spinal cord exposed. Further examination using a surgical microscope was performed to ensure the absence of any remaining axons or neural tissue in the 5-mm gap. In the nerve graft with aFGF group, after laminectomy, 2 complete oblique transverse cuts at T8 were made. The orientation of the cuts allowed the surgeon to distinguish white and gray matter in the 2 stumps of spinal cord. High magnification surgical microscopy also was used to determine that no fibers remained in the 5-mm gap in the spinal cord before transplantation. Eighteen intercostal nerve segments along with a fibrin mixture with aFGF were used to bridge the 5-mm gap (Fig. 1) .
The nerve transplantation with aFGF application surgery was replicated from Cheng's work (7) and included the following steps as described in our previous work (10). 1) Auto-transplantation of 18 intercostal nerve segments: Intercostal nerve segments from the same animal were dissected and placed in Hanks' balanced salt solution, cut to lengths of 6 mm, and placed to bridge the 5-mm lesion gap. 2) White-to-gray matter reconstruction of spinal tracts: Several minced pieces of intercostal nerve segments were used to fill the angle between the 2 stumps of spinal cord, which generated a base providing structural support of the nerve segments that were placed to extend from proximal sites of white matter to distal sites of gray matter. Eighteen fine nerve segments were implanted between the 2 stumps. The intercostal nerve segments were used in an attempt to reconnect tract including corticospinal tracts (dorsal and ventral), vestibulospinal tract, reticulospinal tract, and rubrospinal tract. 3) Fibrin mixture with aFGF: A fibrinbased mixture was used to stabilize the peripheral nerve grafts and fill the damage site. First, aFGF (1 g, R&D Systems, Minneapolis, MN) was added into a solution containing a fibrinogen (100 mg/ml) and aprotinin solution (200 KIU/ml). To this solution was added 10 l thrombin (40 IU/ml) plus calcium chloride (8 mM) to produce an aFGF-containing (2.1 g/ml) mixture (final volume ϳ10 l) that was immediately placed in the grafted site. 4) Vertebral column stabilization: After the nerve transplantation, the T7 to T10 vertebral column was stabilized by wiring, with a compressive S-shaped monofilament surgical steel (B&S gauge 20, DS-20, Ethicon) loop fastened with nonabsorbable threads to the dorsal processes of T7 and T10 vertebrae.
Postoperative Care and Observation
After surgery, the animals were caged separately and placed on thick soft bedding in the individual cage. Heating pads were placed under the cages during the first 3 days after surgery. Manual emptying of the bladders was performed twice daily.
Behavioral Evaluation
All animals received behavioral testing every 2 weeks postsurgery until termination. All behavioral tests were videotaped and all 3 examiners were blind to each group when they participated in behavioral evaluation. The hindlimb locomotor behavior of rats was evaluated by the Basso, Beattie, Bresnahan (BBB) open field locomotion test (11) . Each session lasted 5 minutes. The open field locomotor activity score was determined by observation and scoring of behaviors involving the trunk, tail, and hindlimb. Scores from the 3 examiners were averaged for each rat. Scores ranged from 0 to 21 (0, no movement; 21, normal movement).
The contact placing reflex test also was used in this study. The reflexes were elicited by light touching on dorsal and lateral aspects of each foot. The reflex behavior involved flexion of the limb to clear the edge of the surface, with subsequent extension and placement of the foot onto the surface for support. Scores range from 0 to 2 (0, no placing; 1, weak attempt to place a foot; 2, normal placing).
Anterograde Tract Tracing
Six months after the spinal cord surgery, 12 rats (2 from the sham control group, 5 from the transection-only group, and 5 from the nerve graft with aFGF group) were anesthetized by ketamine (70 mg/kg) and xylazine (8 mg/kg). Bone overlying motor cortex was removed. Electrophysiological recording of tissue responding to hindlimb movement was used to confirm the injection site (1-3 mm posterior to the Bregma and 1-3 mm lateral to the Bregma). Eight injections (4 each side) of 10% fluorescence-labeled biotinylated dextran amine (BDA; Molecular Probes, Eugene, OR) were made bilaterally into motor cortex with a microsyringe (8 ϫ 0.5 l). Two weeks after the BDA injection, the rats were perfused with 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). The spinal cords were collected and longitudinally sliced on a freezing microtome at 20 m thickness. The sections were examined under a fluorescence microscope.
Retrograde Tract Tracing
Six months after the spinal cord surgery, 12 rats (2 from the sham control group, 5 from the transection-only group, and 5 from the nerve graft with aFGF group) were anesthetized with ketamine (70 mg/kg) and xylazine (8 mg/kg) and received laminectomy below the injury site. For the transection-only group and the nerve graft with aFGF group, the exposed spinal cord was transected 10 mm caudal from the injury and pieces of gel foam soaked with 4% fluoro-gold (Fluorochrome Inc., Englewood, NJ) were placed at the transection site. For the sham control group, the placement of fluoro-gold was at transected T11 spinal cord. Animals received the same care as given after the first spinal cord transection. Two weeks later the rats were perfused by 4% paraformaldehyde in phosphate buffer. The brains and spinal cords (C1 to C3 levels) were removed and sliced in the transverse plane at 20 m thickness. The slices were examined using a fluorescence microscope with UV filter. The criteria for positively labeled neuronal cell were 1) bright signal in the cells bodies and processes in comparison to the background environment, 2) labeled cells must have morphological features of neurons (pyramidal or multipolar cell body with labeled proximal dendrites), and 3) the labeled endothelial cells were considered as nonpositive cells.
Immunohistochemistry of Spinal Cord Section
One week and 6 months after the spinal cord surgery, 14 rats (10 from transection-only group, and 4 from nerve graft with aFGF group) were perfused by 4% paraformaldehyde in phosphate buffer (pH 7.4). The spinal cords were collected, immersed in 4% paraformaldehyde in phosphate buffer (pH 7.4) overnight, and then transferred to a 20% sucrose solution. Horizontal or transverse cryosections (20 m thickness) of spinal cord were placed on gelatin-coated slides for immunostaining. Sections were blocked with 3% normal horse serum with 0.25% Triton X-100 in PBS for 1 hour. After blocking, sections were exposed to neurofilament (200 kDa, 1:200 dilution, Chemicon International, Temecula, CA) monoclonal antibody or anti-serotonin polyclonal antibody (1:1500 dilution, DiaSorin, Stillwater, MN) and incubated overnight at 4ЊC. After 3 rinses in PBS, the sections were incubated with rhodamine-conjugated secondary antibodies (Vector Laboratories Inc., 1:100 dilution) for 1 hour at room temperature. After being washed extensively the sections were covered with anti-fading solution and coverslipped and the slides were analyzed under the fluorescence microscope.
Quantitative Analysis of Tract Tracing and 5-HT Intensity Studies
For quantification of BDA-labeled fibers in anterograde tract tracing, the labeled fibers were counted in the graft site and at were analyzed and the number of labeled fibers in each rat of each group was averaged. The BDA-positive fibers with length over 50 m were counted as positive axons.
For quantitative analysis of retrograde tract tracing, the fluoro-gold-labeled cells were counted in cervical spinal cord, motor cortex, and brainstem nuclei (raphe nuclei, vestibular nuclei, reticular formation, and red nuclei). The spinal cords and brains were collected in transverse sections and 1 in every 3 sections was mounted. Twenty sections from cortex and 20 sections from each brainstem nucleus per rat were analyzed and the labeled neurons were counted for each rat and averaged across rats.
For quantification of 5-HT immunoreactivity, the number of labeled axons was counted on sections from the L1 spinal cord. The spinal cords were cut in transverse sections and 1 in every 2 sections was collected. The 5-HT-labeled fibers were examined in ventral horn of spinal cord by counting 5-HT fibers (seen as rhodamine-labeled red dots) under high magnification of fluorescent microscope. Twenty sections per rat were counted and the counts for all rats in each group were averaged.
RESULTS

Complete Transection at T8 Spinal Cord
Gross observation of the spinal cord lesion and the immunostaining of neurofilament around the lesion site were used to demonstrate that the spinal cord was completely transected. Examination showed a 5-mm gap at injured site and white/gray matter could be seen at both spinal cord stumps ( Fig. 2A, B) immediately after transection. The neurofilament staining from 6 rats indicated no fibers were present in the lesion site 1 week after the spinal cord injury (Fig. 2C-E) .
Behavioral Assessment
The behavioral test of hindlimb locomotor activity of all rats in each group was evaluated by the BBB open field test every 2 weeks over the 6-month survival period. BBB test after surgery. The mean BBB scores in both hindlimbs of all rats in the sham group was 21.0 Ϯ 0.05 (mean Ϯ SEM) (Fig. 3) at the 6-month evaluation. The rats in the transection-only group displayed either dragging of hindlimbs or slight movement of 1 joint in 1 hindlimb during the 6-month survival period. No locomotor function improvement was observed in these rats during the 6-month period. The BBB scores of transection-only rats ranged from 0 to 1. The mean BBB scores in both hindlimbs of all rats in transection-only group was 0.7 Ϯ 0.19 (mean Ϯ SEM) (Fig. 3) at the sixth month of evaluation.
In contrast to the results from transection-only group, hindlimb locomotor activity in the rats that received aFGF with nerve transplantation started to show improvement from 4 weeks to 6 months following surgery. Statistical analysis indicated the nerve grafts with aFGF treatment showed significant improvement compared to the transection-only animals starting at 3 months postsurgery (ANOVA, F ϭ 208, p Ͻ 0.001). For example, 6 of 14 rats in this group rats had bilateral hindlimb recovery and their BBB scores ranged between 7 and 9 (i.e. 7.5, 8, 8.5, 8.5, 9, 9) at 6 months postsurgery. They showed either extensive movement of 3 joints or exhibited sweeping with no weight support. The best performance of 2 rats showed weight support in standing or forward stepping and their scores were 10 (maximum score in this study) at 6 months after surgery. In the group 3 rats, 4 of 14 showed different recovery in each hindlimb and their scores ranged between 4 and 7 (i.e. 4.5, 5.5, 6, 6.5). Two of 14 rats showed BBB scores of 3 and 3.5 after 6 months evaluation; these had extensive movement of 2 joints in both hindlimbs. The mean of BBB scores in both hindlimbs of all rats in nerve graft with aFGF group was 7.1 Ϯ 0.61 (mean Ϯ SEM) at the sixth month evaluation (Fig. 3) . Statistical analysis showed a significant difference between transection-only group and aFGF with grafts group (ANOVA, F ϭ 283, p Ͻ 0.001).
In the contact placing test (scores ranged from 0 to 2), the score for sham group rats was 2. Seven of 14 rats in the nerve graft with aFGF group showed bilateral response. Most of their scores reached 1 and some reached 1.5. Five rats exhibited only a unilateral response and 2 rats scored 0. The score in the nerve graft with aFGF group was 1.1 Ϯ 0.16 (mean Ϯ SEM). In contrast to the nerve graft with aFGF group, no contact placing response was observed in any of transection-only rats; their scores were 0. The improvement of contact placing in the nerve graft with aFGF group was significantly greater than the transection-only rats at the end of survival time (ANO-VA, F ϭ 156, p Ͻ 0.001).
Spinal Cord Gross Morphology
At the end of the 6-month survival time the spinal cords of all animals were collected for gross examination. In the nerve graft with aFGF group an opaque white tissue was observed in all animals. This tissue can be considered as a bridge between the spinal stumps and is a good indication of fusion (Fig. 4) . In contrast, thin transparent scar tissue was observed at the transection site in transection-only rats (Fig. 4) . The significant atrophy of the spinal cord stumps around the lesion site was also present in the transection-only animals.
Growth of Corticospinal Tract (CST) into and Below the Injury Site
Five animals from the transection-only group and 5 animals from the nerve-transplanted group were used for anterograde tracing studies at sixth month postsurgery. The spinal cords were collected 2 weeks after the BDA injection into the motor cortex. In 4 of 5 animals in nerve graft with aFGF group, BDA-labeled CST fibers were found in the grafts and below the graft site (Fig. 5A-C) . These CST fibers extended to the lumbar spinal cord and most of them were observed in the white matter. The animal with the lowest BBB score of these 5 animals showed BDA-labeled axons in, but not below, the graft site. There was no BDA-labeled fiber below the transected site in the transection-only rats, although labeled fibers were found in the proximal stump of the spinal cord (Fig. 5D, E) . In quantitative studies of BDA-labeled fibers from nerve graft rats, the number of BDA-labeled axons in the graft site was 68.6 Ϯ 9.27 (mean Ϯ SEM). The number of labeled CST fibers 2 mm below the graft site was 49.8 Ϯ 12.82 (mean Ϯ SEM) and at 5 mm below the graft site was 25.20 Ϯ 7.1 (mean Ϯ SEM) (Fig. 5F ).
Retrogradely Labeled Cells in Cervical Spinal Cord and Brain
Five animals of the transected-only group and 5 animals of the nerve graft with aFGF group have been used for retrograde tracing studies at sixth month postsurgery. Two weeks after fluoro-gold placement in the spinal cord (below the graft site), the brains and spinal cords were collected for further examination. The fluoro-gold-labeled neural cells could be identified in rostral spinal cord, brainstem, and motor cortex in all 5 of animals in nerve graft with aFGF group (Fig. 6A-L) . The labeled neurons in cervical spinal cord were located in both the dorsal horn and ventral horn. The number of labeled neurons (Fig. 6M ) in the cervical spinal cord was 76.6 Ϯ 7.5 (mean Ϯ SEM). In the brainstem, retrogradely labeled neural cells were found in raphe nuclei (656.8 Ϯ 102.1; mean Ϯ SEM), red nuclei (199 Ϯ 35.1; mean Ϯ SEM), reticular formation (1,118 Ϯ 112.2; mean Ϯ SEM), and lateral vestibular nuclei (292.6 Ϯ 56.3; mean Ϯ SEM). In the motor cortex, labeled pyramidal neural cells (68.2 Ϯ 12.1; mean Ϯ SEM) were found in layer V. These labeled pyramidal cells distributed from 1.4 mm rostral to 2.5 mm caudal to the bregma suture. In contrast, no labeled neurons were found in rostral spinal cord or brain in the transection-only animals. group were used for the examination of 5-HT immunoreactivity in the spinal cord below the injury site. In all 4 rats in the nerve graft with aFGF group, 5-HT-positive fibers were observed in and below the graft site. From longitudinal sections of the spinal cord, more labeled fibers were found in the graft site than below the graft site (Fig. 7A1, A2) . In transverse sections, 5-HT fibers were located in the ventral horn and extended into lumber spinal cord (Fig. 7B1, B3 ). In the 4 rats that showed behavioral recovery, 2 rats showed bilateral 5-HT-positive fibers and 2 showed only unilateral 5-HT-positive fibers in lumbar spinal cord. None of transection-only rats showed evidence of 5-HT-positive fibers below the injury site. The number of 5-HT fibers in lumber spinal cord of the aFGF and nerve graft animals was 408.8 Ϯ 8.75 (mean Ϯ SEM), that is, 40% compared to the sham control animals (992 Ϯ 15.3; mean Ϯ SEM) (Fig. 7C) .
5-HT (Serotonin) Immunoreactivity
Correlation of Anterograde and Retrograde Tract Tracing Results and Behavioral Recovery
The nerve graft with aFGF group showed both behavioral improvement and positive results from the tract tracing studies. The relationship between behavioral recovery and tract tracing data in 10 animals was examined (Table). Behavioral BBB scores correlated with anterograde tracing results in nerve graft with aFGF-treated rats. For example, the animal with the greatest number of BDAlabeled fibers in and below the graft site also had the highest BBB score. Statistical analysis showed the number of BDA-labeled fibers and BBB scores had a significant correlation (Fisher's r to z test, correlation coefficiency ϭ 0.916, p Ͻ 0.001) (Fig. 8A ). In addition, there also was a correlation between behavioral BBB scores and retrograde tracing results in nerve graft with aFGF rats. The animal with the greatest number of fluoro-goldlabeled neurons in the cortex and brainstem also had the greatest BBB score. Statistical analysis showed the number of fluoro-gold-labeled neurons from cortex and brainstem and BBB scores had a significant correlation (Fisher's r to z test, correlation coefficiency ϭ 0.983, p Ͻ 0.001) (Fig. 8B) .
DISCUSSION Repair Strategies to Promote Recovery Following Spinal Cord Damage
Evidence for axonal regeneration and partial functional recovery after spinal cord injury has been demonstrated by using a variety of different treatments (7) (8) (9) (12) (13) (14) . These treatments all provide for an environment more conducive to axon growth. The present study followed the technique of Cheng (7) and used transplantation techniques to set up a tissue bridge at the point of injury in order to allow damaged axons to grow across the gap created by the injury. The data of tracing studies in the present study corroborate the results of several studies that have demonstrated that the central nervous system axons could grow into the peripheral nerve grafts (15) (16) (17) . In addition to peripheral nerve graft, several investigators also used fetal tissue, olfactory ensheathing glia, and Schwann cells transplantation to promote axonal regeneration in different spinal cord injury models (9, 18, 19) . These repair strategies all provided a favorable environment to support axonal growth through the damage site.
The data obtained from our previous and present study suggest that axons could establish connections with the distal spinal cord to restore partial locomotion recovery. A previous study reported retrogradely labeled neurons in the cortex and brainstem and labeled CST fibers below the damage site when using the peripheral nerve graft with aFGF repair strategy (7). Furthermore, peripheral nerve graft and aFGF treatment has been shown to promote axonal growth into graft, although not beyond the lesion site, in spinal hemisection of primate model (20) .
The present results also demonstrate the improvement in hindlimb locomotion in BBB scores correlated with the number of retrograde labeled neurons. The results support our previous study, which demonstrated motor evoked responses in hindlimb muscles to cortical stimulation in nerve graft with aFGF-treated animals, and that the improvement of BBB scores correlated with the amplitude of motor evoked potentials (10) . Similarly, Hase et al showed the positive relationship between the number of labeled supraspinal nuclei (including sensorimotor cortex, red nucleus, vestibular nuclei, and raphe nuclei) and BBB scores in spinal cord-repaired neonatal rats (21) .
One of the important factors that could limit the axonal regeneration after spinal cord injury was glia scar formation (22) . Subsequent to spinal cord injury was the proliferation and hypertrophy of astrocytes around the injury site and increased immunoreactivity to glial fibrillary acidic protein (23) . Astrocytes not only present a physical barrier to growth, but also a chemical barrier. After injury, astrocytes express some of the boundary molecules, including chondroitin sulphate proteoglycan and heparin sulphate proteoglycan, that are able to restrict axonal growth (24) . Using chondroitinase treatment to minimize the scar formation has been demonstrated to facilitate axonal regeneration after spinal cord injury (25) .
In addition to scar formation, the nonpermissive environment in the white matter (including myelin-associated glycoprotein) and Nogo (26) are identified as a barrier for axonal regrowth (4, 27) . Nogo-A is a transmembrane protein and expressed by oligodendrocytes in white matter of the CNS. The application of the monoclonal antibody mAb IN-1 was demonstrated to promote axonal regeneration and functional recovery in spinal cord-injured adult rats (28 regeneration. One of them shows that Nogo-A-deficient mice improved CST axonal regrowth after spinal cord injury (29) , while the other demonstrates that the elimination of Nogo-A does not support extensive axonal regeneration (30) .
In the present study, we observed that labeled axons could enter the distal end of host spinal cord. This positive result may be due to the aFGF treatment and the white matter to gray matter reconnecting of nerve grafts. aFGF may downregulate the expression of, or allow axons to overcome, the known inhibitors of axon regeneration such as proteoglycan (31) or tenascins (22, 32) . In brain (33) and spinal cord (34, 35) , aFGF has been shown to induce nerve growth factor production within the injured neocortex and nerve growth factor has been shown to promote the growth of adult axons across reactive scar tissue. Furthermore, placement of nerve grafts to the gray matter in the distal end of spinal cord may guide the axons regrow into the more permissive gray matter environment instead of nonpermissive environment in the white matter.
The Regeneration of Spinal Tracts after the Injury
The CST is one of the important brain tracts projecting to spinal cord that controls motor function in the human, but its role is still not well defined in rats. Several studies have investigated CST recovery following spinal cord damage. The treatment of stem cell or ensheathing cells transplantation (36, 37) , the monoclonal antibody IN-1 (38, 39) , and neurotrophic factors (7, 40) have been demonstrated to facilitate CST fiber regeneration in different acute spinal cord injury models. Furthermore, preligated sural nerve auto-transplantation (41), olfactory ensheathing cells (42) , neurotrophin-3 with monoclonal antibody IN-1 (43) , and the fetal tissue transplantation with neurotrophins (18) all have been used to enhance the CST fibers in chronic spinal cord injury. Previous work also indicated the CST fibers could grow into a graft with aFGF or neurotrophin-3 treatment (7, 14, 17) , although another report showed no CST fibers growing into the nerve graft with brain-derived neurotrophic factor treatment (44) . Additionally, using Schwann cell or fetal tissue transplantation (18, 19) and neurotrophic factors (45) could facilitate supraspinal nuclei (e.g. cerebral cortex, reticular formation, red nucleus, and raphe nucleus) to regenerate axons following contusive or transected spinal cord injury.
We do not know, at present, which of these projection systems is essential for the behavioral recovery. However, even in the normal rat the current level of understanding is incomplete regarding the roles of the different descending motor systems in regulating hind limb performance. Future studies can examine this issue by selective ablation of each system, both in normal and in repaired rats.
Neurotrophic/Neurotrophin Factors in Axonal Regeneration
Neurotrophic factors have been widely used to treat spinal cord injury (17, 19, 43) . These factors can promote axon growth in general and may facilitate axons to cross the damage site. The fibroblast growth factor family members have multiple functions, including being potent modulators of cell proliferation, migration, differentiation, and survival. aFGF is normally produced in the spinal cord by motor neurons and primary sensory neurons (46) . The aFGF acts through tyrosine kinase-type receptor, FGF-R1, and aFGF binds with high affinity to heparin sulfate proteoglycans, which are located on the surface of most cells and within the extracellular matrix (47) . Although aFGF alone can enhance axonal growth (48, 49) , results are optimized when aFGF is used in combination with other supportive factors. In our previous work, both in vitro and in vivo, (10, 50) , we demonstrated that aFGF combined with peripheral nerve transplants provided better axonal regeneration and functional recovery than the individual treatment (either aFGF or peripheral nerve alone).
In summary, we used tract tracing techniques and immunohistochemistry to provide anatomical evidence of axonal regeneration from different neuronal populations in aFGF and peripheral nerve graft treatment. This also confirmed our previous work (10) regarding the electrophysiological data and spinal cord retransection result using the same repair strategy. This surgical technique demonstrated the possibility of axonal regeneration in the completely transected adult mammalian spinal cord. The application of this strategy in the chronic spinal cord injury model or with the other advanced techniques still need to be studied to provide more information for the future clinical work. 
